Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India · Delayed Price · Currency is INR 2,096.50
+63.40 (3.12%)
Jun 8, 2026, 3:30 PM IST
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 160.38 billion as of June 8, 2026. Its market cap has increased by 4.81% in one year.
Market Cap
160.38B
Enterprise Value
151.55B
Revenue
21.87B
Ranking
n/a
PE Ratio
25.01
Stock Price
2,096.50
Market Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 160.38B, an increase of 2,864,423.64%. That is a compound annual growth rate of 52.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 154.41B | 10.33% |
| Dec 31, 2025 | 139.95B | -26.39% |
| Dec 31, 2024 | 190.12B | 84.60% |
| Dec 29, 2023 | 102.99B | 90.47% |
| Dec 30, 2022 | 54.07B | -16.82% |
| Dec 31, 2021 | 65.01B | 69.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 333.07B |
| Wockhardt | 312.13B |
| Piramal Pharma | 221.45B |
| Eris Lifesciences | 189.17B |
| Cohance Lifesciences | 164.92B |
| NATCO Pharma | 160.02B |
| Alembic Pharmaceuticals | 145.14B |
| Alivus Life Sciences | 126.73B |